Company Data
Verona Pharma plc
Ticker
VRNA
Current Price
$67.96 5.87%
Market Cap
$5.6B
Price Target
Refer to Report
Volume
2.1M
52wk Range
$11.39 - $65.5
Overview
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.